Ausam Biotechnologies (Diagnostic Assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Ausam Biotechnologies (Diagnostic Assets) General Information

Description

A patent protected diagnostic asset. The diagnostic known as Accumin(TM) is used for detection, measurement and quantitation of the protein albumin in urine.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • 645 Madison Avenue
  • Suite 502
  • New York, NY 10022
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ausam Biotechnologies (Diagnostic Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ausam Biotechnologies (Diagnostic Assets)‘s full profile, request access.

Request a free trial

Ausam Biotechnologies (Diagnostic Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ausam Biotechnologies (Diagnostic Assets)‘s full profile, request access.

Request a free trial